Representing Oxbryta Victims

Home » drug injury » oxbryta

Following a nationwide recall of Oxbryta by the Food and Drug Administration (FDA), the announcement sent shockwaves through families relying on the drug to treat sickle cell disease. The recall cited concerns about quality control failures that could affect the effectiveness and safety of the medication, leaving patients vulnerable to serious health risks. Those who are already struggling with a life-threatening condition have filed Oxbryta recall lawsuits to seek justice for the resulting harm.

Ferrer Poirot Feller has advocated for victims of defective products for over four decades now. Our Oxbryta recall lawyers can stand strong against powerful drug manufacturers and recover compensation for those harmed by unsafe products. If you or a loved one suffered complications after taking Oxbryta, contact us immediately to assess whether you may qualify to file a lawsuit.

Schedule a Free Consultation

Key Takeaways: Oxbryta Recall Lawsuits

• Oxbryta was pulled from the market in 2024 after reports linked it to serious and sometimes life-threatening conditions in patients with sickle cell disease.
• Damages in lawsuits may include medical bills, lost income, long-term disability, and wrongful death claims, depending on how the drug impacted a patient’s life.
• Eligibility requires proof of Oxbryta use, diagnosis of sickle cell disease, and evidence of worsening health or new conditions tied to the medication.
• Potential injuries include kidney failure, liver damage, stroke, bone necrosis, and pulmonary hypertension, among other severe complications.
• Work with our Oxbryta recall lawsuit lawyers to help gather medical evidence, challenge the manufacturers, and ensure your suffering is fully recognized in court.

Why Was Oxbryta Recalled?

Pfizer, the manufacturer of Oxbryta (voxelotor), initiated a voluntary recall of all lots of the drug in September 2024 following an analysis of clinical trial data that revealed significant safety risks for patients with sickle cell disease. The decision was based on findings from the HOPE trial and its extension study, which revealed an imbalance in the occurrence of severe pain and tissue damage resulting from blocked blood flow. Sadly, there was also a higher number of fatal events among those taking the medication compared to the placebo group.

This imbalance prompted Pfizer to conclude that the potential benefits of Oxbryta no longer justified the associated dangers, leading to the cessation of distribution worldwide and notifications to healthcare providers and patients to discontinue use immediately. These concerns were deemed severe enough by the FDA to issue an alert urging immediate discontinuation.

In the wake of the recall, multiple lawsuits have been filed against Pfizer and its subsidiary Global Blood Therapeutics, alleging that the companies failed to adequately warn about the drug’s risks despite emerging evidence from clinical trials. These actions primarily fall under product liability theories, including claims of defective design, manufacturing flaws, and negligence in marketing and labeling. Plaintiffs are asserting that the medication caused or worsened vaso-occlusive crises, severe anemia, and even death.

As of early September 2025, Oxbryta recall lawsuits are still in the early stages, but the litigation is gaining momentum. Defective drug attorneys have filed lawsuits for clients from various states in federal and state courts. Possibly, the Judicial Panel on Multidistrict Litigation may consolidate the cases into multidistrict litigation, given the numerous lawsuits pending.

Why Choose Our Oxbryta Recall Lawsuit Lawyers

For the nearly four decades we have been in practice, Ferrer Poirot Feller has built a reputation for standing up to some of the largest pharmaceutical companies in the country. When patients are harmed by drugs that should have protected them, we are prepared to take aggressive legal action to hold manufacturers accountable. Here is why we remain trusted for taking on challenging defective product cases:

• Respected Nationwide: Our firm is widely recognized across the U.S. for our work in complex drug and medical device litigation. This national reputation gives us the leverage to negotiate from a position of strength and to ensure clients receive fair treatment.

• Trial-Ready Representation: While many cases settle, we prepare every case as if it is going to trial. This approach strengthens our clients’ claims and sends a clear message to manufacturers and insurers that we will not back down.

• Proven Results: Over the years, we’ve recovered hundreds of millions of dollars for injured patients. Every victory secures justice for the client and helps pave the way for future victims to obtain fair compensation.

Choosing us means partnering with a legal team that knows how to take on powerful corporations and fight tirelessly for patients who have been let down by the very drugs they trusted. If you are suffering harm after using Oxbryta, be sure to contact our firm for legal support.

Compensation in Oxbryta Recall Lawsuits

Although no trials, verdicts, or publicly announced settlements have been issued in the Oxbryta litigation, patients harmed by this recalled medication are still taking legal action. The goal is not only to ease the financial burdens caused by the drug’s side effects but also to recognize the profound physical and emotional toll.

Victims of the Oxbryta recall frequently describe a life marked by pain, uncertainty, and a loss of trust in their medical treatment. Many were managing sickle cell disease, already a life-altering condition, when they turned to Oxbryta with the hope of improved health. Instead, they were met with new complications that disrupted their stability and, in some cases, led to lasting harm.

Attorneys representing Oxbryta victims seek damages across several categories:

• Medical Expenses: Patients may incur additional hospitalizations, diagnostic tests, or treatments to address complications resulting from Oxbryta. These costs can pile up quickly, and lawsuits aim to secure funds to cover past and anticipated medical needs.

• Loss of Income: Serious complications can sideline patients from their jobs. For some, the inability to work extends indefinitely, making it necessary to pursue compensation for lost income and future earning potential.

• Pain and Suffering: Beyond the financial losses lies the day-to-day reality of pain, weakness, and uncertainty about long-term health. Compensation in this area reflects the suffering endured, including the emotional impact of being harmed by a medication that was supposed to provide relief.

• Loss of Quality of Life: Maintaining even a health baseline requires immense effort for patients managing sickle cell disease. Complications from Oxbryta may strip away the ability to engage in daily routines, enjoy time with loved ones, or plan for the future. These losses are intangible but deeply felt.

• Wrongful Death Damages: In cases where Oxbryta complications contributed to a patient’s death, families may be entitled to damages for funeral expenses, loss of companionship, and the financial void left behind.

With sickle cell disease affecting an estimated 8 million people worldwide, many individuals likely placed their trust in this treatment. That means the scope of potential lawsuits can be extensive. For those harmed, our defective drug attorneys work to ensure that the compensation pursued reflects the lasting disruption to health, stability, and quality of life.

Who Qualifies for an Oxbryta Lawsuit?

Families who placed their trust in Oxbryta and suffered harm may be entitled to pursue legal action. If you or a loved one experienced serious health problems after taking the drug, or if a family member passed away, you may qualify to file a lawsuit.

Many lawsuits allege that Oxbryta caused or contributed to severe, life-altering conditions, including:

• Acute chest syndrome
• Arthritis and joint damage
• Blood clots
• Bone necrosis (bone tissue death)
• Kidney failure
• Leg ulcers
• Liver failure
• Pneumonia and other serious infections
• Pulmonary hypertension
• Sleep apnea and other sleep-related disorders
• Splenic sequestration (blood pooling in the spleen)
• Stroke
• Vision loss

To establish eligibility, you will need to show:

• Proof of diagnosis and prescription confirming that you or your loved one had sickle cell disease and were prescribed Oxbryta.
• Evidence that your health declined, new complications developed, or your loved one’s condition worsened after starting Oxbryta.
• Medical findings or expert testimony linking the injuries to the use of the drug.

Ensure you are working with an attorney who concentrates on prescription drug litigation. Our Oxbryta recall lawsuit lawyers have the knowledge and resources to review medical records, consult with experts, and present the strongest possible case for compensation. We stand ready to help determine whether your circumstances qualify and ensure your voice is heard.

We Can Help Fight the Manufacturers and Their Insurers

Taking on a global pharmaceutical company and its insurers is not something most families can do on their own. These corporations are equipped with teams of attorneys whose sole purpose is to minimize payouts and shield the company from liability. For patients harmed by Oxbryta, that means every claim will be met with resistance, denial, or attempts to settle for less than what the case is truly worth.

Our law firm boasts decades of experience handling complex pharmaceutical cases, and we are familiar with the tactics these companies employ and how to counter them effectively. We have frequently observed the following tactics used by the manufacturers of defective products and their insurers:

• Denying liability or minimizing the drug’s risks
• Delaying litigation through procedural motions
• Shifting blame to prescribing physicians or patients
• Challenging causation between drug use and injuries
• Offering low initial settlement amounts
• Withholding or disputing internal safety data
• Leveraging arbitration clauses in patient agreements
• Public relations campaigns to downplay recall severity

To counter bad faith tactics associated with the defendants, we partner with medical specialists, economists, and other experts to demonstrate how Oxbryta caused harm and its long-term effect on your health, finances, and quality of life. We don’t spare our resources when pursuing these cases, because we work to secure justice for the individuals and families severely affected by Oxbryta.

You won’t face this fight alone when you have us on your side. We will help you every step of the way, from collecting medical evidence to challenging the insurance companies, and if necessary, we’ll take your case to trial.

Oxbryta Recall Lawsuits FAQs

Work With Ferrer Poirot Feller Toward Justice

With the numerous Oxbryta recall lawsuits pending, victims of Oxbryta usage can secure significant recoveries. Our drug injury attorneys are ready to investigate your case, gather the evidence needed to prove your claim, and fight for the compensation that reflects the full scope of your suffering. The sooner you engage us, the sooner we can begin building the foundation for your lawsuit and protecting your rights. Contact Ferrer Poirot Feller at (214) 521-4412 for a free consultation. We are committed to fighting for your rights.

Schedule a Free Consultation